What is the difference between Live Events and Major Conferences?

Congress in session right now across Europe. These are active catalyst windows — not upcoming listings. Editorially curated tier-1 congresses on the EMA calendar — selected for market-moving history, attendance scale, and pipeline density.

Conference intelligence

Pharma Event Intelligence Platform

Track global conferences, regulatory summits, and clinical congresses with coverage, company intelligence, and networking signals.

11 Upcoming

0 Live now

8 Therapeutic areas

🇪🇺

Europe & United Kingdom Pharma Events

EMA-regulated pharmaceutical news, drug approvals, and clinical trial updates for the European market. Track EMA-market congresses, regulatory summits, and clinical meetings with NovaPharmaNews coverage.

Industry radar

What's moving in Europe

Updated 2026-06-19

1 congress live in Europe

EULAR 2026 is underway — check live coverage for data readouts and partnership signals.

2 events in the next 14 days

A dense catalyst window for EMA-market BD, investor positioning, and clinical data anticipation.

3 tier-1 conferences through 60 days

Major congresses drive pipeline narratives, licensing windows, and sell-side estimate revisions across Europe & United Kingdom.

General leads the Europe calendar

2 upcoming events cluster in general — the highest sector density in the next 60 days.

3 presentations indexed

3 companies mapped across upcoming Europe congresses — pipeline and investor-impact scoring applied.

58+ editorial articles linked

Preview briefs, live dispatches, and post-event analysis from NovaPharmaNews editorial — not an automated scrape.

Editorial intelligence

Why Europe pharma events matter now

Europe & United Kingdom pharma events are not calendar entries — they are catalyst clusters where clinical data, regulatory posture, and partnership timing converge. In the next 60 days, 3 tier-1 conferences and 2 near-term meetings shape how investors and BD teams allocate attention across the EMA corridor.

The highest-conviction watchlist centers on EUROoCS Annual Meeting, ESMO Gastrointestinal Cancers Congress, Pharmaceutical Sciences and Innovations. These congresses historically move consensus estimates, trigger licensing conversations, and surface competitive readouts that ripple into 12–18 month pipeline valuations.

NovaPharmaNews links 58+ published articles to this calendar — combining presentation intelligence, company mapping, and editorial analysis rather than republishing organizer agendas.

Executives & investors

Prioritize tier-1 congresses (3 in 60 days) where management commentary and data readouts reset guidance.

Business development

Use live and pre-event windows for partnering — 3 companies already indexed across upcoming programs.

Clinical & regulatory

0 regulatory forums plus therapeutic-area congresses set submission strategy and trial-design benchmarks for EMA markets.

How to read this page

Two sections serve different intelligence needs. Live Events are active congresses; Major Conferences are editor-selected tier-1 planning priorities on the EMA calendar.

Live Events

Congress in session right now across Europe. These are active catalyst windows — not upcoming listings.

Real-time presentation and company signals as sessions run
Breaking coverage and data-readout alerts where editorial is filed
Highest urgency for investors monitoring same-day market moves

Major Conferences

Editorially curated tier-1 congresses on the EMA calendar — selected for market-moving history, attendance scale, and pipeline density.

Tier-1 global or major designation — not every regional meeting
Pre-event briefs, key-data previews, and investor-impact scoring
Planning horizon: BD outreach, travel, and competitive intelligence prep

Analyst watchlist

Most important events — next 60 days

3 ranked · impact-weighted

1

EUROoCS Annual Meeting Jun 22 – 24, 2026

EUROoCS 2026 (Braga, 22–24 June) is the definitive European gathering for Organ-on-Chip and microphysiological systems, where national initiatives and regulator…

Tier 1 Global general Impact 77
2

ESMO Gastrointestinal Cancers Congress Jul 1 – 4, 2026

This congress is the premier global forum for GI oncology data, focusing on biomarker-driven therapies and early detection across colorectal, pancreatic, and he…

Tier 1 Global oncology Impact 65
3

Pharmaceutical Sciences and Innovations Jul 27 – 28, 2026

This 26th World Congress on Pharmaceutical Sciences in Rome (July 2026) is a broad EU academic-industry congress covering generic drug discovery, formulation, a…

Tier 1 Global general Impact 55

Corporate intelligence

Companies most active across events

Sponsors and presenters with the broadest congress footprint in Europe over the next 60 days.

1
Bristol-Myers Squibb$BMY1 event · 1 abstract
Single high-signal presentation at ESMO Gastrointestinal Cancers Congress.
ESMO Gastrointestinal Cancers Congress
2
Roche1 event · 1 abstract
Single high-signal presentation at Pharmaceutical Sciences and Innovations.
Pharmaceutical Sciences and Innovations
3
CN Bio1 event · 1 abstract
Single high-signal presentation at EUROoCS Annual Meeting.
EUROoCS Annual Meeting

Pipeline intelligence

Drug pipelines to watch

INN-level readouts indexed from upcoming congress abstracts — ranked by investor-impact score.

1
nivolumab(Opdivo, Yervoy)Bristol-Myers Squibb
On the ESMO Gastrointestinal Cancers Congress agenda in unresectable hepatocellular carcinoma (first-line).
unresectable hepatocellular carcinoma (first-line)

Sector intelligence

Therapeutic area intelligence

Where congress density, tier-1 flagships, and presentation coverage cluster in Europe.

General

2 events2 tier-12 abstracts

EUROoCS Annual Meeting · Pharmaceutical Sciences and Innovations

2 upcoming general events (2 tier-1) — flagship: EUROoCS Annual Meeting, Pharmaceutical Sciences and Innovations. 2 presentations indexed. Cross-therapeutic congresses attract diversified BD pipelines — useful for platform deals and multi-indication licensing.

Oncology

1 events1 tier-11 abstracts

ESMO Gastrointestinal Cancers Congress

1 upcoming oncology events (1 tier-1) — flagship: ESMO Gastrointestinal Cancers Congress. 1 presentations indexed. Oncology congresses drive the highest density of registrational readouts and label-expansion catalysts — priority for investors and clinical teams.

Analyst watch

Desk notes on upcoming congresses

Investor, regulatory, and competitive implications distilled from event intelligence — not organizer marketing copy.

EUROoCS Annual Meetinggeneral

Analyst view

Key catalysts to monitor: any disclosed regulatory submission timelines for MPS-based data packages, and partnership deals between MPS vendors and top-20 pharma. Absence of major safety signals on novel multi-organ chips…

EUROoCS Annual Meetinggeneral

Investor desk

Look for announcements of new multi-organ MPS platforms and validation data from industry partners; positive readouts could accelerate licensing deals for CROs and MPS providers.

EUROoCS Annual Meetinggeneral

Regulatory affairs

The meeting's focus on standardization and regulatory dialog indicates progress toward EMA qualification of specific MPS assays, a key catalyst for broader industry adoption.

EUROoCS Annual Meetinggeneral

Competitive intelligence

Firms with proprietary MPS technologies (e.g., CN Bio, Dynamic42) will compete for visibility against academic consortia; expect partnership announcements as big pharma scouts for validated models.

EUROoCS Annual Meetinggeneral

Market access

EU-funded initiatives on MPS standardization will shape procurement patterns; CROs integrating MPS into routine toxicity screening may gain a near-term edge.

EUROoCS Annual Meetinggeneral

Industry strategy

The consensus on MPS as a complement (not full replacement) to animal models will reinforce multi-pronged preclinical strategies, with PK/PD modeling a key session area.

Specialized calendars

Congress intelligence by desk

Clinical readouts, EMA forums, partnering windows, and market-moving congresses — curated for Europe, not a raw directory export.

Clinical data calendar

Indexed abstracts, trial phases, and NCT-linked readouts across upcoming congresses.

Jul 27
oral
ADA26: T1 and T2 diabetes readouts from Roche, MannKind and Lilly
Pharmaceutical Sciences and Innovations · Roche
Jul 1
nivolumab(Opdivo, Yervoy)poster
Efficacy results from a MAIC suggest potential benefit with nivolumab/ipilimumab over other first-line IO-based regimens in first-line unresectable HCC
ESMO Gastrointestinal Cancers Congress · Bristol-Myers Squibb

Market-moving conferences

Ranked by editorial coverage, abstract density, and tier-1 designation — investor desk priority.

1
EUROoCS Annual Meeting72
Jun 22 – Jun 24, 2026
Market-moving score 72 (tier-1 · 1 articles · 1 abstracts indexed) — historically drives estimate revisions and sector rotation.
2
ESMO Gastrointestinal Cancers Congress55
Jul 1 – Jul 4, 2026
Market-moving score 55 (tier-1 · 1 abstracts indexed) — historically drives estimate revisions and sector rotation.
3
Pharmaceutical Sciences and Innovations55
Jul 27 – Jul 28, 2026
Market-moving score 55 (tier-1 · 1 abstracts indexed) — historically drives estimate revisions and sector rotation.

Personal intelligence

Build your event watchlist

Follow congresses, companies, pipeline programs, or therapeutic areas. Weekly digest + catalyst alerts — no account required.

Major Europe Conferences

Editor-selected tier-1 congresses — planning priorities, not a complete directory.

EUROoCS Annual Meeting

Braga, Portugal • Jun 22 – Jun 24, 2026

EUROoCS 2026 (Braga, 22–24 June) is the definitive European gathering for Organ-on-Chip and microphysiological systems, where national initi…

Pharma Event Intelligence Platform

What's moving in Europe

1 congress live in Europe

2 events in the next 14 days

3 tier-1 conferences through 60 days

General leads the Europe calendar

3 presentations indexed

58+ editorial articles linked

Why Europe pharma events matter now

How to read this page

Live Events

Major Conferences

Most important events — next 60 days

Companies most active across events

Drug pipelines to watch

Therapeutic area intelligence

Desk notes on upcoming congresses

Clinical data calendar

Market-moving conferences

Build your event watchlist

Event watchlist

Follow company

Follow drug program

Follow therapeutic area

Major Europe Conferences

Recently Concluded — Europe

Stay Ahead in Pharma